Delivery Order SPE2DB20D2104-SPE2DB24FU87F

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,093.51, is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S. This is a Firm Fixed Price delivery order contract with an ultimate completion date of April 2, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,341.97, is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 18, 2025 and is structured as a firm fixed-price delivery order. The contract was not subject to any set-aside requirements. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,138.11, is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $4,405.84 and a period of performance through January 23, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,883.80 firm fixed-price delivery order contract covers the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025 and was awarded on February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,070.04, is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S. This appears to be part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,122.21, is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $2,019.38. It is not a set-aside contract. The contract is for the provision of the pharmaceutical product MYRBETRIQ ER 25 MG TABLET 30S. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,711.19 firm-fixed-price delivery order is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2024 and was awarded on July 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $7,978.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product, with a completion date of May 5, 2025. The contract is a Firm Fixed Price agreement and is not a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU87F
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,838.02, is a Firm Fixed Price Delivery Order for the supply of the pharmaceutical product MYRBETRIQ ER 25 MG TABLET 90S. The contract has an ultimate completion date of June 26, 2024.

This contract appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award did not utilize any set-aside requirements, indicating open competition. AmerisourceBergen is the prime contractor, and there is no mention of any subcontractors in the provided information.

Generated 5/17/25, 10:07 AM